|
PGK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.346400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.359200E-01 |
| Normal-vs-Stage2 |
5.722800E-01 |
| Normal-vs-Stage3 |
1.026240E-01 |
| Normal-vs-Stage4 |
7.948000E-01 |
| Stage1-vs-Stage2 |
3.237400E-01 |
| Stage1-vs-Stage3 |
4.699900E-02 |
| Stage1-vs-Stage4 |
8.981200E-01 |
| Stage2-vs-Stage3 |
5.523200E-01 |
| Stage2-vs-Stage4 |
5.898200E-01 |
| Stage3-vs-Stage4 |
2.508200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.679400E-01 |
| Normal-vs-AfricanAmerican |
9.384000E-01 |
| Normal-vs-Asian |
9.125600E-01 |
| Caucasian-vs-AfricanAmerican |
9.173000E-01 |
| Caucasian-vs-Asian |
8.676600E-01 |
| AfricanAmerican-vs-Asian |
8.998600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.977180E-01 |
| Normal-vs-Female |
7.899800E-03 |
| Male-vs-Female |
3.019300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.840600E-01 |
| Normal-vs-Extreme_Weight |
7.897800E-02 |
| Normal-vs-Obese |
1.851780E-01 |
| Normal-vs-Extreme_Obese |
5.917400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.545000E-01 |
| Normal_Weight-vs-Obese |
2.034000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.464400E-01 |
| Extreme_Weight-vs-Obese |
2.535700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.619400E-01 |
| Obese-vs-Extreme_Obese |
3.267200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.621000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.513200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.074000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.901000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.260400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.931000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.431400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.178000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.887600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.082000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.667800E-02 |
| Normal-VS-Type2 PRCC |
4.680100E-02 |
| Normal-VS-KIRP CIMP |
6.962600E-01 |
| Normal-VS-Unclassified PRCC |
3.200000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.343500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.348600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.110000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.367400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.751400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.775000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.437200E-01 |
| Normal-vs-N1 |
9.535600E-01 |
| Normal-vs-N2 |
4.090400E-01 |
| N0-vs-N1 |
7.318200E-01 |
| N0-vs-N2 |
2.726000E-01 |
| N1-vs-N2 |
1.837630E-01 |
|
|
